Activity and Safety Study of BKM120 in Monotherapy in Patient With Metastatic Head and Neck Cancer Recurrent or Progressive

NCT01737450 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Neoplasms
Neoplasm Metastasis
Recurrent Disease
Progressive Disease

Interventions

DRUG: BKM120

Sponsor

Centre Leon Berard

Collaborators

[object Object]
[object Object]